{"id":"W4286294392","doi":"10.1200/jco.2022.40.16_suppl.11541","title":"Patient reported outcomes and tolerability in patients receiving ripretinib versus sunitinib after imatinib treatment in INTRIGUE: A phase 3 open-label study.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Deciphera Pharmaceuticals","keywords":"Medicine; Tolerability; Sunitinib; Adverse effect; Internal medicine; Clinical endpoint; Quality of life (healthcare); GiST; Gastroenterology; Surgery; Randomized controlled trial; Cancer; Stromal cell","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00441886,0.0002123575,0.001857523,0.0002808869,0.00006634249,0.00002267471,0.0001612761,0.00006756122,0.0002332189],"category_scores_gemma":[0.01005804,0.0001491891,0.0001537411,0.0002836091,0.0001246948,0.0001333548,0.000398949,0.001106186,0.000002117509],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001119311,"about_ca_system_score_gemma":0.001233525,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003310068,"about_ca_topic_score_gemma":0.0005097657,"domain_scores_codex":[0.9932777,0.001907177,0.003449747,0.0003791433,0.0006083088,0.0003779474],"domain_scores_gemma":[0.9943338,0.003096939,0.001484466,0.0003136346,0.0003022772,0.0004688649],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.06563739,0.08263019,0.7260767,0.000008627398,0.000207328,0.007711654,0.0005510559,0.000003035117,0.000001489205,0.000001344062,0.00003909556,0.1171321],"study_design_scores_gemma":[0.1431874,0.1800789,0.6747761,0.00004795848,0.0001198174,0.0001452215,0.0009594731,0.00003147871,0.000002200919,0.00003613834,0.0005459448,0.00006930097],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9952043,0.00006038308,7.189756e-7,0.001858821,0.0004249673,0.001913442,0.00001389259,0.000005428762,0.0005180949],"genre_scores_gemma":[0.9979377,0.00002737143,0.001472212,0.0002392758,0.00004346213,0.000216058,0.000009972746,0.00001592748,0.00003806997],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1170628,"threshold_uncertainty_score":0.9982806,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2290711850459004,"score_gpt":0.5292887835417361,"score_spread":0.3002175984958357,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}